Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

6 Oct 2017 08:00

RNS Number : 8775S
Medaphor Group PLC
06 October 2017
 

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

 

Completion of Acquisition

Total Voting Rights

Director/PDMR Shareholding

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that following admission today of 56,477,285 new ordinary shares of 1 pence each ("Ordinary Shares") relating to the placing to raise approximately £5.5 million and the Company's proposed acquisition of Intelligent Ultrasound Limited for a total consideration of up to £3.6 million, both the placing and the acquisition have completed.

 

Following admission, the share capital of the Company will consist of 90,701,443 Ordinary Shares. Therefore, the total number of voting rights in the Company is 90,701,443 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company.

 

The Company makes the following disclosures in respect of the participation in the Placing by persons discharging managerial responsibilities and persons closely associated, in accordance with article 19(3) of the Market Abuse Regulation:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

IP Group plc

2

Reason for the notification

a)

Position/status

Person closely associated - David Baynes, Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MedaPhor Group plc

 

b)

LEI

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

ISIN: GB00BN791Q39

b)

Nature of the transaction

Purchase of ordinary shares of 1 pence each as part of a placing

Consideration payable in ordinary shares of 1 pence each as part of an acquisition

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

12.50 pence

16,000,000

 

 

16.22 pence

5,055,320

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

16,000,000 (being the placing shares)

- Price

£2,000,000

 

- Aggregate volume

 

- Price

 

 

 

5,055,320 (being the consideration shares)

 

£819,972.90

e)

Date of the transaction

6 October 2017

f)

Place of the transaction

XLON

 

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel: +44 (0)20 7397 8900

Bobbie Hilliam (Nominated Advisor)

 

Michael Johnson / Julian Morse (Corporate Broking)

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

About MedaPhor (www.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops advanced hi-fidelity haptic and manikin based training simulators, clinical image analysis software tools, augmented reality based needle guidance software and artificial intelligence based automated scanning software for all medical practitioners.

 Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

 Ultrasound Simulation and Training

 Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Point-of-Care simulator platform (launching January 2018). Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

 Intelligent Ultrasound

 Focuses on developing augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. ScanNav uses machine-learning based algorithms to automatically access and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSUFWIFWSEIS
Date   Source Headline
23rd May 20177:00 amRNSAGM Statement
26th Apr 20177:00 amRNSNotice of AGM
4th Apr 20172:53 pmRNSGrant of options
22nd Mar 20178:35 amRNSFinal Results
26th Jan 201711:30 amRNSPatent Infringement Settlement & Trading update
16th Dec 20167:24 amRNSPatent Infringement Settlement
27th Oct 20167:00 amRNSNew Ultrasound Simulation Suite with ScanTrainer
22nd Sep 20167:00 amRNSDirector appointment
15th Sep 20167:00 amRNSScanTrainer Professional approved for CPD points
12th Sep 20167:00 amRNSBSE approves HeartWorkd eLearn for TOE syllabus
8th Sep 20167:01 amRNSLaunch of new ScanExaminer simulator
8th Sep 20167:00 amRNSNotice of material contract change
12th Aug 20162:40 pmRNSHolding(s) in Company
3rd Aug 20167:01 amRNSAcquisition
3rd Aug 20167:00 amRNSHalf-year Report
5th Jul 20167:00 amRNSMedaphor North America expands US sales team
29th Jun 20167:00 amRNSUpdates to ScanTrainer Professional 2016 version
11th May 201611:20 amRNSResult of AGM
11th May 20167:00 amRNSAGM Statement
27th Apr 20167:00 amRNSNotice of Patent Infringement Proceedings
20th Apr 201610:49 amRNSHolding(s) in Company
19th Apr 201612:05 pmRNSResult of General Meeting
8th Apr 201611:28 amRNSNotice of AGM
1st Apr 20167:00 amRNSFinal Results
1st Apr 20167:00 amRNSPlacing to raise £3.2 million
1st Mar 20167:00 amRNSMedaPhor signs agreement with ABOG
18th Jan 20167:00 amRNSLaunch of Cloud 2 service
8th Dec 20158:43 amRNSCorrection: Trading Update
8th Dec 20157:00 amRNSTrading Update
26th Nov 20157:00 amRNSMedaPhor signs reseller partner in France
11th Nov 20157:00 amRNSContract win with Teesside University
27th Oct 20157:00 amRNSMedaPhor expands into Spain and Portugal
1st Oct 20157:00 amRNSContract Win
8th Sep 20157:00 amRNSScanTrainer passes patient case milestone
30th Jul 20157:00 amRNSInterim Results
13th Jul 20157:00 amRNSEnhancement to ScanTrainer product portfolio
24th Jun 20157:00 amRNSCollaboration with Inventive Medical
6th May 201512:15 pmRNSResult of AGM
6th May 20157:01 amRNSAGM Statement
30th Apr 20157:00 amRNSScanTrainer released in French, German and Spanish
2nd Apr 20157:00 amRNSExpansion into South Africa
1st Apr 20157:00 amRNSNotice of AGM
12th Mar 20157:00 amRNSPreliminary Results
3rd Mar 20157:00 amRNSScanTrainer released in Chinese and Japanese
28th Jan 20157:00 amRNSInnovators & Investors Forum
26th Jan 201510:12 amRNSNew module launched to enhance product offering
8th Jan 20157:00 amRNSTrading Statement
19th Dec 20142:28 pmRNSIssue of Equity
11th Nov 20147:00 amRNSLaunch of software update and cloud connectivity
24th Sep 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.